Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$252.74 USD
+4.06 (1.63%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $253.00 +0.26 (0.10%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth C Momentum F VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 38% (96 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.53 | 1.59 | 9.99 |
Current Quarter Estimate | -7.58 | -1.21 | 61.00 |
Year Ago Quarter Estimate | -5.34 | -0.07 | 54.84 |
Next Quarter Estimate | -5.91 | -1.90 | 63.00 |
Next Year Estimate | -17.76 | 12.55 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -38.42 | 19.70 | 15.67 |
Next Year | 35.81 | 15.20 | 11.34 |
Last 5 Years | -303.80 | 7.00 | 8.10 |
Next 5 Years | NA | 22.60 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.96 |
Price/Book (MRQ) | 6.40 | 1.54 |
Price/Cash Flow (MRFY) | NA | 8.95 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -61.35% |
Return on Equity (TTM) | -95.61% | -58.93% |
Debt to Equity (MRQ) | 0.14 | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.